The in vitro activities of penicillin, erythromycin, clindamycin, and telithromycin were determined against 155 viridans group streptococci (VGS) and 18 Streptococcus bovis blood isolates. Heterogeneity in the susceptibility patterns and macrolide resistance phenotypes and genotypes in the different groups of VGS was detected. We found seven telithromycin-resistant S. bovis isolates all harboring the erm(B) gene.
Of the 155 VGS, 72 isolates belonged to the S. mitis group; other groups included Streptococcus anginosus (49 isolates), Streptococcus sanguis (21 isolates), Streptococcus salivarius (11 isolates), and Streptococcus mutans (2 isolates).
The in vitro activities of the antibiotics tested for the different streptococci, except for the two S. mutans group isolates, which were susceptible to all antibiotics tested, are shown in Table 1 .
Overall, the rate of nonsusceptibility to penicillin was 29%. Of the 50 penicillin-nonsusceptible strains, 13 (8%) were highly resistant to penicillin and 37 (21%) showed intermediate resistance. S. mitis showed the highest rate of penicillin resistance (45%). Moreover, of the 13 highly penicillin-resistant strains, 12 belonged to the S. mitis group and one belonged to the S. salivarius group. These results agree with other surveys which report that penicillin resistance is more common in S. mitis and S. salivarius than in S. anginosus (1, 7, 8) .
The resistance percentages for erythromycin and clindamycin were 45.6 and 27.7%, respectively. High percentages (30 to 50%) of erythromycin resistance have been reported in recent studies of VGS isolated from blood cultures (1, (5) (6) (7) . Resistance to erythromycin varied by species, and Streptococcus bovis group isolates showed the highest rates of resistance to erythromycin and clindamycin. S. bovis isolates were found to be more resistant to these antibiotics than other streptococcal species in Denmark were (14) . The lowest percentages of erythromycin and clindamycin resistance were found in S. salivarius isolates.
Overall the ketolide telithromycin was the most active antimicrobial agent tested, with 96% susceptibility. However, we found seven telithromycin-resistant strains. These belonged to the S. bovis group, and the MICs for them ranged from 4 to 128 g/ml. Telithromycin-resistant VGS have been recently reported in Belgium (11) , but, to our knowledge, ours is the first report that describes telithromycin-resistant S. bovis strains and the first that shows MICs as high as 128 g/ml.
Of the 79 erythromycin-resistant strains, 61% displayed constitutive macrolide-lincosamide-streptogramin B (cMLS B ) resistance, 35% displayed the M phenotype, and 4% displayed the inducible MLS B (iMLS B ) phenotype ( Table 2 ). The predominance of the cMLS B phenotype in VGS isolated from blood has been reported from Korea (61.1%), France (77%), and Holland (73%) (3, 9, 22) . However, in the United States, Canada, and Latin America (6, 8) , the M phenotype was the most common. In VGS isolated from normal flora, there are also differences between phenotypes in the different countries (2, 11, 17) In our study, the cMLS B phenotype was the most predominant in S. anginosus and S. bovis, while in S. sanguis and S. salivarius the most frequent was the M phenotype. Jacobs et al. (9) reported that 73% of S. anginosus strains studied had the cMLS B phenotype strains, and for S. bovis, Rennenberg et al. (14) reported a high percentage of strains with the cMLS B phenotype. However, in the study by Teng et al. (21) in Taiwan, iMLS B was the most common phenotype in 38 erythromycin-resistant S. bovis isolates.
Therefore, the proportions of the different phenotypes may vary according to country and source of strains and may even depend on the groups of VGS that are included in the studies.
The erm(B) gene was amplified in all strains with the cMLS B and iMLS B phenotypes and was negative for all isolates with the M phenotype. mef(A) was detected in most isolates with the M phenotype as well as in eight isolates with a cMLS B phenotype. These strains were S. mitis (four), S. anginosus (three), and S. bovis (one). As in previous studies of VGS (8, 11, 13) , we did not find any differences in MICs between the strains harboring the erm(B) and mef(A) genes and those harboring erm(B) alone. Therefore, the MIC makes it impossible to know which genes are present in each strain and whether it is necessary to perform a genotypic analysis. No erm(B), erm(A), erm(C), or mef(A) genes were detected in one S. mitis isolate with the M phenotype. Figure 1 shows the distribution of macrolide resistance genes according to telithromycin MICs. The strains harboring the mef(A) gene showed a range of Յ0.015 to 0.25 g/ml, while all strains for which the MIC was Ն0.5 g/ml harbored the erm(B) gene, either alone or with the mef(A) gene. All telithro- Thus, telithromycin resistance in streptococci might depend either on the species, at the level of erm(B) gene expression, as occurs in S. pneumoniae, or on an additional mechanism.
The results of the present investigation and the data from the literature suggest that the clinical microbiology laboratory should carry out an accurate identification of VGS at species level, as differences in the patterns of susceptibility to the antimicrobial agents and in the mechanisms responsible for this resistance are observed. The finding of S. bovis group isolates showing telithromycin resistance implies the necessity of further studies to determine the mechanisms responsible for this resistance.
